News | October 06, 2008

ATS Medical Launches CryoMaze Surgical Ablation Clamp

October 7, 2008 - ATS Medical Inc. last week launched U.S. sales of the ATS CryoMaze Surgical Ablation Clamp.

The launch of this product marks the first ablation product development effort by ATS since the product line was acquired from CryoCath Technologies. The ATS CryoMaze Clamp is similar in clinical use to other ablation clamps on the market; however, it uses argon-based cryoablation to create lesions rather than heat-based RF energy. The benefit of this ablation clamp over competitive devices is a unique ablation window that allows the surgeon to visually confirm complete freezing of the targeted tissue, the company said. Early prototype testing and evaluation was performed with the assistance of Evelio Rodriguez, M.D., of East Carolina University, who has also used the clamp in clinical practice.

“Some other ablation clamps must be applied multiple times and then tested to see if they work,” said Dr. Rodriguez. “But with the ATS CryoMaze Clamp, you apply it once and, because you can see the frost coming through, you know that it worked with a single application.”

For more information: www.atsmedical.com


Related Content

News

Feb. 6, 2026 — Abbott has announced new clinical data from two late-breaking presentations at AF Symposium in Boston ...

Home February 06, 2026
Home
News

Jan. 20, 2026 — Abbott has received CE Mark in Europe for the TactiFlex Duo Ablation Catheter, Sensor Enabled to treat ...

Home January 22, 2026
Home
News

Jan. 20, 2026 — Kardium Inc. has announced the publication of the PULSAR clinical trial results in the Journal of the ...

Home January 21, 2026
Home
Feature | Kyle Hardner

Robotic Magnetic Navigation (RMN) emerged two decades ago as an alternative approach to performing complex ablation ...

Home January 09, 2026
Home
News

Jan. 6, 2026 — Stereotaxis, a supplier of surgical robotics for minimally invasive endovascular intervention, has ...

Home January 06, 2026
Home
News

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
Home
News

Sept. 2, 2025 — Johnson & Johnson MedTech has announced acute safety and effectiveness results from the Varipure ...

Home September 05, 2025
Home
News

Sept. 3, 2025 — Kardium Inc. recently announced it has received pre-market approval (PMA) for the Globe Pulsed Field ...

Home September 03, 2025
Home
News

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
Home
News

July 7, 2025 — Catheter ablation is a minimally invasive treatment for abnormal heart rhythms. It is often successful in ...

Home July 09, 2025
Home
Subscribe Now